Products

Murine coronavirus cDNA and Antigen

Cat#

Product Name

Swiss Prot#

Size

Price (US$)

Order

PN1220

Recombinant Protein-Murine coronavirus Spike protein S1 (a.a.15 to 415)

P11224

100 µg

1195

Order

PN1221

Recombinant Protein-Murine coronavirus Spike protein S2 (a.a.718 to 1118)

P11224

100 µg

1195

Order

PN1222

Recombinant Protein-Murine coronavirus inf-MHV-A59 Nucleocapsid protein (a.a.51 to 454)

C0KYY3

100 µg

1195

Order

RPN1220

cDNA-Murine coronavirus Spike protein S1 (a.a.15 to 415)

P11224

2 µg

2000

Order

RPN1221

cDNA-Murine coronavirus Spike protein S2 (a.a.718 to 1118)

P11224

2 µg

2000

Order

RPN1222

cDNA-Murine coronavirus inf-MHV-A59 Nucleocapsid protein (a.a.51 to 454)

C0KYY3

2 µg

2015

Order

Murine coronavirus cDNA and recombinant antigen

  • Codon-optimized cDNA is cloned into E. coli expression vector with 6x His-tag at N-terminus and ready-to-use for recombinant protein production.
  • Recombinant protein applications: Western Blot may be used for other applications determined by the user.
  • Protein Purity: >90%, as determined by SDS-PAGE under reducing conditions.
  • Protein Activity: N/A
  • Protein Tag:  Contains A 6x histidine tag at N-terminus.
  • Protein Formulation: Liquid
  • Source: Produced from E. coli

Murine coronavirus is a type of coronavirus that infects mice and is a valuable model system for studying the pathogenesis of human coronaviruses. The virus is composed of several proteins, including the spike proteins S1 and S2, which are important for virus entry into host cells, and the nucleocapsid protein, which is involved in viral replication and packaging.

The spike protein S1 and S2 are the major components of the viral envelope and are responsible for viral entry into host cells by binding to the host cell receptor. The nucleocapsid protein is a structural protein that packages the viral RNA genome and plays an important role in viral replication.

Studies of murine coronavirus have contributed significantly to our understanding of coronavirus biology and pathogenesis and have helped to inform the development of therapeutics and vaccines for human coronavirus infections.

The use of recombinant proteins/cDNA in academic research and therapeutic applications has skyrocketed. However, in heterologous expression systems, successful recombinant protein expression is dependent on a variety of factors, including codon preference, RNA secondary structure, and GC content. When compared to pre-optimization, more and more experimental results demonstrated that the expression level was dramatically increased, ranging from two to hundred times depending on the gene. Bioclone has created a proprietary technology platform that has resulted in the creation of over 6,000 artificially synthesized codon-optimized cDNA clones (cloned in E.coli expression Vector), which are ready for production of the recombinant proteins.

Welcome to BitClone

Magnetic Beads Make Things Simple